Clinical Trials Logo

Clinical Trial Summary

PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart failure. This feasibility trial will enroll 10 subjects at up to 7 sites in the US. The primary objectives of this investigational device exemption (IDE) clinical investigation are to assess the feasibility of using the Jarvik 2015 in pediatric patients with severe heart failure who require mechanical circulatory support. Feasibility will be assessed by evaluating the safety profile of the Jarvik 2015 device in eligible subjects.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02954497
Study type Interventional
Source Carelon Research
Contact
Status Active, not recruiting
Phase Early Phase 1
Start date October 22, 2018
Completion date September 15, 2023

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05017077 - Home Monitoring in Pediatric Heart Failure N/A
Completed NCT02678312 - Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure Phase 2/Phase 3